An interventional study of MI training in Behavior Change Interventions, Evaluation and Training Effectiveness, sponsored by Geisinger Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Geisinger Clinic · Not applicable, Interventional, and Health services research
The goal of this study is to evaluate the impact of motivational interviewing (MI) training for Geisinger clinicians on their patients' health outcomes. Clinicians will be randomly assigned to attend or not attend mandated MI training, which will be provided at one of several sessions offered beginning in August 2026. Randomization will be stratified by department to ensure participant balance and that participating departments maintain necessary staffing levels during the training period. The study will assess whether there is a significant increase in patients' positive health behaviors and outcomes, as reflected in an index measure of multiple outcomes that may reasonably be facilitated by MI training: vaccinations and health screenings as reflected in electronic health record care gaps. Smoking cessation and other lifestyle modifications, preventive medication adherence, and behavioral health use may also be examined as part of an overall measure of MI impact. For each clinician assigned to the study, all patients they see in the 90-day period following the (would-be) date of that clinician's training will be identified and enrolled in the study. Outcome timeframes will then be relative to each unique patient's first encounter following (would-be) training.
719 studies on the registry are indexed under Communication; 159 are open to participants now.
This study's planned enrollment of 180,000 is above the median of 144 across 571 interventional studies indexed under Communication.
Browse Communication studies →Geisinger Clinic is the lead sponsor of 127 studies on the registry; 17 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.
Compared within Communication, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Clinician Inclusion Criteria:
Patient Inclusion Criteria:
Exclusion Criteria:
Clinician is assigned to attend an MI training session
Behavioral: MI training
Clinician is not assigned to MI training
Clinicians will be instructed to register for one MI training session that will be conducted live and in person, with possible virtual training available for those unable to attend in person
Proportion of care gaps addressed
Proportion of open care gaps closed
Time frame: Within 180 days following initial patient encounter, as of day following (would-be) assigned MI training session
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2026 (actual). Primary completion is estimated for Aug 2028, 24 months after the start.
Of 390 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's planned 24 months is above that.
Counting every sponsor, half of 394 studies reached it within 18 months; a quarter within 6 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.